Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) (CARTIER)
Cardiotoxicity in the Elderly. Comparative Clinical Trial Between Primary Versus Secondary Cardiovascular Prevention Strategies
Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Listed as NCT03711110, this NA trial focuses on Antineoplastic Agents and Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma) and remains actively recruiting participants. Sponsored by Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León, it has been updated 13 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Apr 2025 — Sep 2025 [monthly]
Recruiting NA
-
Sep 2024 — Apr 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Jun 2022 — Dec 2023 [monthly]
Recruiting NA
-
Feb 2021 — Jun 2022 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Dec 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Dec 2019 [monthly]
Not Yet Recruiting NA
-
Mar 2019 — Sep 2019 [monthly]
Not Yet Recruiting NA
-
Feb 2019 — Mar 2019 [monthly]
Not Yet Recruiting NA
-
Nov 2018 — Feb 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
- Instituto de Investigación Biomédica de Salamanca
- Instituto de Salud Carlos III
For direct contact, visit the study record on ClinicalTrials.gov .